Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-06-10 4:02 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | Deep Track Capital LP | 2,436,164 5.19% | 2,436,164 (New Position) | View |
| 2022-02-14 5:07 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | Redmile Group LLC | 2,958,284 6.6% | 112,159 (+3.94%) | View |
| 2022-02-14 4:57 pm Sale | 13G | NURIX THERAPEUTICS INC NRIX | Third Rock Ventures III L.P. | 2,550,757 5.7% | -2,871,792 (-52.96%) | View |
| 2022-02-14 4:15 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | BAKER BROS. ADVISORS LP | 2,454,082 5.5% | 2,454,082 (New Position) | View |
| 2022-02-14 2:35 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | PRICE T ROWE ASSOCIATES INC | 4,871,084 10.9% | 244,189 (+5.28%) | View |
| 2022-02-11 4:34 pm Sale | 13G | NURIX THERAPEUTICS INC NRIX | COLUMN GROUP L P | 654,245 1.5% | -6,101,636 (-90.32%) | View |
| 2022-02-11 3:11 pm Sale | 13G | NURIX THERAPEUTICS INC NRIX | Foresite Capital Fund IV L.P. | 1,205,798 2.7% | -2,045,051 (-62.91%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | BlackRock Inc. BLK | 2,547,861 5.7% | 2,547,861 (New Position) | View |
| 2022-02-04 09:21 am Sale | 13G | NURIX THERAPEUTICS INC NRIX | WELLINGTON MANAGEMENT GROUP LLP | 1,162,316 2.61% | -1,285,268 (-52.51%) | View |
| 2021-08-10 1:41 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | PRICE T ROWE ASSOCIATES INC | 4,626,895 10.4% | 4,626,895 (New Position) | View |
| 2021-02-16 4:15 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | Third Rock Ventures III L.P. | 5,422,549 14% | 5,422,549 (New Position) | View |
| 2021-02-16 4:11 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | Redmile Group LLC | 2,846,125 7.3% | 2,846,125 (New Position) | View |
| 2021-02-16 11:08 am Purchase | 13G | NURIX THERAPEUTICS INC NRIX | Foresite Capital Fund IV L.P. | 3,250,849 8.4% | 90,065 (+2.85%) | View |
| 2021-02-12 6:16 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | COLUMN GROUP L P | 6,755,881 17.4% | 6,755,881 (New Position) | View |
| 2021-02-04 09:51 am Sale | 13G | NURIX THERAPEUTICS INC NRIX | WELLINGTON MANAGEMENT GROUP LLP | 2,447,584 6.3% | -1,628,396 (-39.95%) | View |
| 2020-08-10 09:43 am Purchase | 13G | NURIX THERAPEUTICS INC NRIX | WELLINGTON MANAGEMENT GROUP LLP | 4,075,980 10.78% | 4,075,980 (New Position) | View |
| 2020-08-03 3:28 pm Purchase | 13G | NURIX THERAPEUTICS INC NRIX | Foresite Capital Fund IV L.P. | 3,160,784 8.5% | 3,160,784 (New Position) | View |